I'm in the same camp as you, Chab. My post was a response to JohnKing and his post #17771.
I just finished reading all of the news items for Amarin on Yahoo and I am absolutely LIVID !!! There wasn't a single piece that accurately reported what the FDA AdComm did to Amarin yesterday. The result of the voting was an injustice of massive proportion fomented by a group of "so-called" professionals who demonstrated an inexcusable misunderstanding of the underlying science and benefits of using Vascepa.
But every one of these articles alluded to Amarin continuing the Reduce-It Trial as a moral obligation. Really? They actually have the cojones to put that on Amarin after the FDA's absolutely immoral debacle with that ridiculous AdComm.
I don't see why we as investors nor the company as an injured party should feel an obligation to do anything but attempt to survive! If that means playing hardball on Reduce-It, so be it. If we can put together a position document to present as Citizen Advocates, great! If we could conjure a way to make some of the FDA bozos and Panel Members look like bigger fools than they already do, fantastic.
But the company needs to get priorities straight right now! The company needs to start revealing to investors what moves it plans on making....now and going forward. Enough with the BS information blackouts to keep our competitors in the dark! Had management paid more attention to the knowledge base on this MB, we wouldn't be dealing with this shitstorm now!
I'm not a big proponent of lawsuits, especially not with government agencies. In my experience, the only real winners are the lawyers. But if Amarin management plans on running this business as usual, I'm going to be getting on the bandwagon with Humphrey, Dumphrey and Moe, LLC, and joining in a Class Action. Amarin might have been setup by the FDA, but THERE IS NO EXCUSE for the lack of preparation going into this AdComm....and that failure has cost us dearly.
